No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Anti-Anxiety Agents / administration & dosage
-
Anti-Anxiety Agents / therapeutic use
-
Antidepressive Agents / administration & dosage
-
Antidepressive Agents / therapeutic use
-
Antidepressive Agents, Tricyclic / administration & dosage
-
Antidepressive Agents, Tricyclic / therapeutic use
-
Anxiety Disorders / diagnosis
-
Anxiety Disorders / drug therapy
-
Anxiety Disorders / therapy
-
Bipolar Disorder / diagnosis
-
Cyclohexanols / administration & dosage
-
Cyclohexanols / therapeutic use
-
Depressive Disorder / diagnosis
-
Depressive Disorder / drug therapy
-
Depressive Disorder / etiology
-
Depressive Disorder / psychology
-
Depressive Disorder / therapy
-
Diagnosis, Differential
-
Drug Therapy, Combination
-
Electroconvulsive Therapy
-
Female
-
Hospitalization
-
Humans
-
Male
-
Mood Disorders* / diagnosis
-
Mood Disorders* / drug therapy
-
Mood Disorders* / psychology
-
Mood Disorders* / therapy
-
Personality Disorders / diagnosis
-
Pregnancy
-
Prognosis
-
Psychotherapy
-
Psychotropic Drugs / administration & dosage
-
Psychotropic Drugs / therapeutic use
-
Recurrence
-
Schizophrenia / diagnosis
-
Selective Serotonin Reuptake Inhibitors / administration & dosage
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Suicide
-
Time Factors
-
Venlafaxine Hydrochloride
-
Young Adult
Substances
-
Anti-Anxiety Agents
-
Antidepressive Agents
-
Antidepressive Agents, Tricyclic
-
Cyclohexanols
-
Psychotropic Drugs
-
Serotonin Uptake Inhibitors
-
Venlafaxine Hydrochloride